Pure Biologics (Poland) Probability of Future Stock Price Finishing Over 15.4
| PUR Stock | 14.00 0.22 1.60% |
Pure |
Pure Biologics Target Price Odds to finish over 15.4
The tendency of Pure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 15.40 or more in 90 days |
| 14.00 | 90 days | 15.40 | over 95.19 |
Based on a normal probability distribution, the odds of Pure Biologics to move over 15.40 or more in 90 days from now is over 95.19 (This Pure Biologics Splka probability density function shows the probability of Pure Stock to fall within a particular range of prices over 90 days) . Probability of Pure Biologics Splka price to stay between its current price of 14.00 and 15.40 at the end of the 90-day period is under 4.
Assuming the 90 days trading horizon Pure Biologics Splka has a beta of -1.11 indicating Additionally Pure Biologics Splka has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Pure Biologics Price Density |
| Price |
Predictive Modules for Pure Biologics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pure Biologics Splka. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pure Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pure Biologics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pure Biologics is not an exception. The market had few large corrections towards the Pure Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pure Biologics Splka, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pure Biologics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.6 | |
β | Beta against Dow Jones | -1.11 | |
σ | Overall volatility | 2.14 | |
Ir | Information ratio | -0.18 |
Pure Biologics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pure Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pure Biologics Splka can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pure Biologics Splka generated a negative expected return over the last 90 days | |
| Pure Biologics Splka has high historical volatility and very poor performance |
Pure Biologics Technical Analysis
Pure Biologics' future price can be derived by breaking down and analyzing its technical indicators over time. Pure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pure Biologics Splka. In general, you should focus on analyzing Pure Stock price patterns and their correlations with different microeconomic environments and drivers.
Pure Biologics Predictive Forecast Models
Pure Biologics' time-series forecasting models is one of many Pure Biologics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pure Biologics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pure Biologics Splka
Checking the ongoing alerts about Pure Biologics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pure Biologics Splka help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pure Biologics Splka generated a negative expected return over the last 90 days | |
| Pure Biologics Splka has high historical volatility and very poor performance |
Additional Tools for Pure Stock Analysis
When running Pure Biologics' price analysis, check to measure Pure Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Biologics is operating at the current time. Most of Pure Biologics' value examination focuses on studying past and present price action to predict the probability of Pure Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Biologics' price. Additionally, you may evaluate how the addition of Pure Biologics to your portfolios can decrease your overall portfolio volatility.